PaxMedica, Inc. (PXMD)
OTCMKTS
· Delayed Price · Currency is USD
0.0640
-0.0020 (-3.03%)
Dec 24, 2024, 9:30 AM EST
PaxMedica Statistics
Total Valuation
PaxMedica has a market cap or net worth of 776,015. The enterprise value is 451,534.
Market Cap | 776,015 |
Enterprise Value | 451,534 |
Important Dates
The next estimated earnings date is Wednesday, March 12, 2025.
Earnings Date | Mar 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
PaxMedica has 11.31 million shares outstanding. The number of shares has increased by 606.41% in one year.
Current Share Class | n/a |
Shares Outstanding | 11.31M |
Shares Change (YoY) | +606.41% |
Shares Change (QoQ) | +3.20% |
Owned by Insiders (%) | 0.72% |
Owned by Institutions (%) | 8.07% |
Float | 10.77M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.03 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.38
Current Ratio | 0.38 |
Quick Ratio | 0.15 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -11,794.75 |
Financial Efficiency
Return on equity (ROE) is -7,716.49% and return on invested capital (ROIC) is -909.14%.
Return on Equity (ROE) | -7,716.49% |
Return on Assets (ROA) | -324.69% |
Return on Capital (ROIC) | -909.14% |
Revenue Per Employee | n/a |
Profits Per Employee | -2.52M |
Employee Count | 7 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.00% in the last 52 weeks. The beta is -0.54, so PaxMedica's price volatility has been lower than the market average.
Beta (5Y) | -0.54 |
52-Week Price Change | -92.00% |
50-Day Moving Average | 0.10 |
200-Day Moving Average | 0.26 |
Relative Strength Index (RSI) | 42.57 |
Average Volume (20 Days) | 49,803 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.07 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -15.44M |
Pretax Income | -17.66M |
Net Income | -17.66M |
EBITDA | n/a |
EBIT | -15.44M |
Earnings Per Share (EPS) | -3.51 |
Balance Sheet
Cash & Cash Equivalents | 324,486 |
Total Debt | n/a |
Net Cash | 324,486 |
Net Cash Per Share | 0.03 |
Equity (Book Value) | -1.81M |
Book Value Per Share | -0.23 |
Working Capital | -1.31M |
Cash Flow
Operating Cash Flow | -9.32M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PaxMedica does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -606.41% |
Shareholder Yield | -606.41% |
Earnings Yield | -5,118.40% |
FCF Yield | n/a |
Stock Splits
The last stock split was on October 31, 2023. It was a reverse split with a ratio of 0.0588235.
Last Split Date | Oct 31, 2023 |
Split Type | Reverse |
Split Ratio | 0.0588235 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |